Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Devico

Showing results (21-30 of 124) with videos related to

Pageof 13
Sort By:
Virology|November 1, 1991
Purification and partial characterization of equine infectious anemia virus reverse transcriptaseA DeVico, R C Montelaro, R C Gallo, et al.
Journal of Virology|May 8, 2023
The SETD2 Methyltransferase Supports Productive HPV31 Replication through the LEDGF/CtIP/Rad51 PathwayMichelle Mac, Brianna M DeVico, Sophia M Raspanti, et al.
Virology|April 1, 1996
Covalently crosslinked complexes of human immunodeficiency virus type 1 (HIV-1) gp120 and CD4 receptor elicit a neutralizing immune response that includes antibodies selective for primary virus isolatesA Devico, A Silver, A M Thronton, et al.
Journal of Virology|November 12, 2005
Induction of neutralizing antibodies against human immunodeficiency virus type 1 primary isolates by Gag-Env pseudovirion immunizationJason Hammonds, Xuemin Chen, Timothy Fouts, et al.
Journal of Translational Medicine|January 25, 2022
Identifying CCR5 coreceptor populations permissive for HIV-1 entry and productive infection: implications for in vivo studiesMatthew Weichseldorfer, Yutaka Tagaya, Marvin Reitz, et al.
Antimicrobial Agents and Chemotherapy|March 30, 2006
Preclinical evaluation of synthetic -2 RANTES as a candidate vaginal microbicide to target CCR5Tina M Kish-Catalone, Wuyuan Lu, Robert C Gallo, et al.
The Journal of Experimental Medicine|November 17, 1998
A new monoclonal antibody, mAb 4A12, identifies a role for the glycosaminoglycan (GAG) binding domain of RANTES in the antiviral effect against HIV-1 and intracellular Ca2+ signalingJ M Burns, R C Gallo, A L DeVico, et al.
ACS Omega|August 18, 2025
ACE2 Receptor and Antibody Binding to SARS-CoV‑2 Spikes and Virions by Single-Molecule FluorescenceSouradip Dasgupta, Srijan Ray, Aswin T Srivatsav, et al.
Immunological Reviews|January 4, 2001
The role of chemokines in human immunodeficiency virus infectionA Garzino-Demo, A L DeVico, K E Conant, et al.
Journal of Virology|January 16, 2015
Conserved molecular signatures in gp120 are associated with the genetic bottleneck during simian immunodeficiency virus (SIV), SIV-human immunodeficiency virus (SHIV), and HIV type 1 (HIV-1) transmissionMileidy W Gonzalez, Anthony L DeVico, George K Lewis, et al.
Pageof 13

Showing results (21-30 of 124) with videos related to

Sort By:
Pageof 13
Virology|November 1, 1991
Purification and partial characterization of equine infectious anemia virus reverse transcriptaseA DeVico, R C Montelaro, R C Gallo, et al.
Journal of Virology|May 8, 2023
The SETD2 Methyltransferase Supports Productive HPV31 Replication through the LEDGF/CtIP/Rad51 PathwayMichelle Mac, Brianna M DeVico, Sophia M Raspanti, et al.
Virology|April 1, 1996
Covalently crosslinked complexes of human immunodeficiency virus type 1 (HIV-1) gp120 and CD4 receptor elicit a neutralizing immune response that includes antibodies selective for primary virus isolatesA Devico, A Silver, A M Thronton, et al.
Journal of Virology|November 12, 2005
Induction of neutralizing antibodies against human immunodeficiency virus type 1 primary isolates by Gag-Env pseudovirion immunizationJason Hammonds, Xuemin Chen, Timothy Fouts, et al.
Journal of Translational Medicine|January 25, 2022
Identifying CCR5 coreceptor populations permissive for HIV-1 entry and productive infection: implications for in vivo studiesMatthew Weichseldorfer, Yutaka Tagaya, Marvin Reitz, et al.
Antimicrobial Agents and Chemotherapy|March 30, 2006
Preclinical evaluation of synthetic -2 RANTES as a candidate vaginal microbicide to target CCR5Tina M Kish-Catalone, Wuyuan Lu, Robert C Gallo, et al.
The Journal of Experimental Medicine|November 17, 1998
A new monoclonal antibody, mAb 4A12, identifies a role for the glycosaminoglycan (GAG) binding domain of RANTES in the antiviral effect against HIV-1 and intracellular Ca2+ signalingJ M Burns, R C Gallo, A L DeVico, et al.
ACS Omega|August 18, 2025
ACE2 Receptor and Antibody Binding to SARS-CoV‑2 Spikes and Virions by Single-Molecule FluorescenceSouradip Dasgupta, Srijan Ray, Aswin T Srivatsav, et al.
Immunological Reviews|January 4, 2001
The role of chemokines in human immunodeficiency virus infectionA Garzino-Demo, A L DeVico, K E Conant, et al.
Journal of Virology|January 16, 2015
Conserved molecular signatures in gp120 are associated with the genetic bottleneck during simian immunodeficiency virus (SIV), SIV-human immunodeficiency virus (SHIV), and HIV type 1 (HIV-1) transmissionMileidy W Gonzalez, Anthony L DeVico, George K Lewis, et al.
Pageof 13